n-methyl-3,4-methylenedioxyamphetamine has been researched along with sch 23390 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 8 (61.54) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| McGregor, IS; van Nieuwenhuijzen, PS | 1 |
| Brennan, KA; Carati, C; Fitzmaurice, PS; Lea, RA; Schenk, S | 1 |
| Cunningham, KA; dela Cruz, AM; Grady, JJ; Herin, DV | 1 |
| Harkin, A; McNamara, R; Vanattou-Saïfoudine, N | 1 |
| Harper, DN | 1 |
| Aguilar, MA; Daza-Losada, M; Miñarro, J; Rodríguez-Arias, M; Roger-Sánchez, C; Vidal-Infer, A | 1 |
| Higashiyama, K; Kazawa, H; Mochizuki, A; Mori, T; Shibasaki, M; Suzuki, T; Uzawa, N; Watanabe, H; Yoshizawa, K | 1 |
| Harper, DN; Harrow, CC; Macaskill, AC | 1 |
| Ball, KT; Hyacinthe, J; Jarsocrak, H; Lambert, J; Lockowitz, J; Schrock, J | 1 |
| Furukawa, S; Iwamura, T; Mamiya, T; Matsumoto, Y; Mouri, A; Nabeshima, T; Nitta, A; Niwa, M; Noda, Y; Yamada, K | 1 |
| Chen, Z; Dolan, SB; Gatch, MB; Huang, R | 1 |
| Fukase, M; Iwase, Y; Mochizuki, A; Mori, T; Shibasaki, M; Suzuki, T; Takahashi, Y; Uzawa, N | 1 |
| Baker, LE; Cargile, KJ; Lunn, JA; Thomas, AM | 1 |
13 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and sch 23390
| Article | Year |
|---|---|
Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry.
Topics: Animals; Baclofen; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Flumazenil; Hypothermia; Illicit Drugs; Male; Methamphetamine; Morpholines; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Rats; Rats, Wistar; Ritanserin; Sodium Oxybate; Telemetry | 2009 |
Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats.
Topics: Animals; Antipsychotic Agents; Benzazepines; Central Nervous System; Cocaine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Methamphetamine; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Self Administration | 2009 |
Novel approach to data analysis in cocaine-conditioned place preference.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Cocaine; Conditioning, Psychological; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intraperitoneal; Male; Models, Animal; N-Methyl-3,4-methylenedioxyamphetamine; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Serotonin Receptor Agonists; Time Factors | 2009 |
Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA ('ecstasy').
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Body Weight; Caffeine; Central Nervous System Stimulants; Dopamine Agents; Drug Interactions; Hallucinogens; Heart Rate; Locomotion; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Sulpiride; Time Factors | 2010 |
Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists.
Topics: Analysis of Variance; Animals; Benzazepines; Cocaine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Injections, Intraperitoneal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Psychomotor Performance; Rats; Receptors, Dopamine D1; Recognition, Psychology; Salicylamides; Time Factors | 2013 |
Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.
Topics: Animals; Benzazepines; Blotting, Western; Conditioning, Operant; Dopamine; Dopamine Antagonists; Haloperidol; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Raclopride; Serotonin; Thiazepines | 2012 |
Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Discrimination Learning; Dose-Response Relationship, Drug; Male; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT2; Receptors, sigma; Sigma-1 Receptor | 2014 |
The disruptive effects of methamphetamine on delayed-matching-to-sample performance reflect proactive interference and are reduced by SCH23390.
Topics: Amphetamine-Related Disorders; Animals; Benzazepines; Central Nervous System Stimulants; Disease Models, Animal; Dopamine Antagonists; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2015 |
Yohimbine reinstates extinguished 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats with prior exposure to chronic yohimbine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Addictive; Benzazepines; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Feeding Behavior; Food; Hallucinogens; Male; N-Methyl-3,4-methylenedioxyamphetamine; Random Allocation; Rats, Sprague-Dawley; Self Administration; Stress, Psychological; Yohimbine | 2015 |
The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
Topics: Animals; Behavioral Symptoms; Benzazepines; Brain; Brain-Derived Neurotrophic Factor; Conditioning, Operant; Dopamine; Dopamine Antagonists; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hallucinogens; Locomotion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Phosphopyruvate Hydratase; Raclopride; RNA, Messenger; Serotonin | 2017 |
"Ecstasy" to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Conditioning, Operant; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Drug Combinations; Hallucinogens; HEK293 Cells; Humans; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Self Administration; Serotonin; Substance-Related Disorders | 2018 |
Synergistic effects of MDMA and ethanol on behavior: Possible effects of ethanol on dopamine D
Topics: Animals; Benzazepines; Dopamine Antagonists; Ethanol; Haloperidol; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |
Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
Topics: Animals; Benzazepines; Benzodioxoles; Central Nervous System Stimulants; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Hallucinogens; N-Methyl-3,4-methylenedioxyamphetamine; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sex Factors; Synaptic Transmission; Synthetic Cathinone | 2021 |